These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7981987)

  • 1. Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up.
    Paimela L; Leirisalo-Repo M; Risteli L; Hakala M; Helve T; Risteli J
    Br J Rheumatol; 1994 Nov; 33(11):1012-6. PubMed ID: 7981987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression.
    Hakala M; Risteli J; Aman S; Kautiainen H; Korpela M; Hannonen P; Leirisalo-Repo M; Laasonen L; Paimela L; Möttönen T;
    Scand J Rheumatol; 2008; 37(2):90-3. PubMed ID: 18415764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study.
    Aman S; Paimela L; Leirisalo-Repo M; Risteli J; Kautiainen H; Helve T; Hakala M
    Rheumatology (Oxford); 2000 Sep; 39(9):1009-13. PubMed ID: 10986307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased type I collagen degradation in early rheumatoid arthritis.
    Kotaniemi A; Isomäki H; Hakala M; Risteli L; Risteli J
    J Rheumatol; 1994 Sep; 21(9):1593-6. PubMed ID: 7799334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.
    Hakala M; Risteli L; Manelius J; Nieminen P; Risteli J
    Ann Rheum Dis; 1993 Dec; 52(12):866-9. PubMed ID: 8311537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis.
    Sassi ML; Aman S; Hakala M; Luukkainen R; Risteli J
    Clin Chem Lab Med; 2003 Aug; 41(8):1038-44. PubMed ID: 12964811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased type I collagen degradation correlates with disease activity in reactive arthritis.
    Kotaniemi A; Risteli J; Aho K; Hakala M
    Clin Exp Rheumatol; 2003; 21(1):95-8. PubMed ID: 12673897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
    Elomaa I; Virkkunen P; Risteli L; Risteli J
    Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study.
    Aman S; Risteli J; Luukkainen R; Risteli L; Kauppi M; Nieminen P; Hakala M
    Ann Rheum Dis; 1999 Sep; 58(9):559-62. PubMed ID: 10460189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease.
    Valleala H; Laasonen L; Koivula MK; Mandelin J; Friman C; Risteli J; Konttinen YT
    J Rheumatol; 2003 Mar; 30(3):468-73. PubMed ID: 12610803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis.
    Hakala M; Aman S; Luukkainen R; Risteli L; Kauppi M; Nieminen P; Risteli J
    Ann Rheum Dis; 1995 Nov; 54(11):886-90. PubMed ID: 7492237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I collagen degradation does not diminish with RA disease duration.
    Hakala M; Aho K; Aman S; Luukkainen R; Kauppi M; Risteli J
    Ann Rheum Dis; 2001 Apr; 60(4):420-2. PubMed ID: 11247878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
    St Clair EW; Moak SA; Wilkinson WE; Sanders L; Lang T; Greenwald RA
    J Rheumatol; 1998 Aug; 25(8):1472-9. PubMed ID: 9712086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
    Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
    Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis.
    Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M
    Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.
    Ueno T; Hashimoto O; Sugawara H; Ogata R; Kusaba N; Torimura T; Sata M; Tanikawa K
    Int J Oncol; 1998 Aug; 13(2):297-303. PubMed ID: 9664125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
    Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
    Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.